Anaplastic thyroid carcinoma: Treatment outcome and prognostic factors

Cancer

Volumn 103, Issue 7, 2005, Pages 1330-1335

  Kebebew, Electron ^a,b,d   Greenspan, Francis S ^c   Clark, Orlo H ^a,b   Woeber, Kenneth A ^c   McMillan, Alex ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anaplastic thyroid carcinoma; Epidemiology; Prognostic factors; Radiotherapy; Survival; Thyroidectomy

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ANAPLASTIC CARCINOMA; ANAPLASTIC THYROID CARCINOMA; ARTICLE; BEAM THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; DEMOGRAPHY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; THYROID CARCINOMA; THYROIDECTOMY; TREATMENT OUTCOME; TUMOR LOCALIZATION; TUMOR VOLUME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CARCINOMA; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 15744362272     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20936     Document Type: Article

References (38)

1. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see comments]. Cancer. 1998;83:2638-2648.
2. Kitamura Y, Shimizu K, Nagahama M, et al. Immediate causes of death in thyroid carcinoma: clinicopathological analysis of 161 fatal cases. J Clin Endocrinol Metab. 1999;84: 4043-4049.
3. Aldinger KA, Samaan NA, Ibanez M, Hill CS Jr. Anaplastic carcinoma of the thyroid: a review of 84 cases of spindle and giant cell carcinoma of the thyroid. Cancer. 1978;41:2267-2275.
4. Besic N. The role of initial debulking surgery in the management of anaplastic thyroid carcinoma. Surgery. 2003;133: 453-454; author reply, 454-455.
5. Busnardo B, Daniele O, Pelizzo MR, et al. A multimodality therapeutic approach in anaplastic thyroid carcinoma: study on 39 patients. J Endocrinol Invest. 2000;23:755-761.
6. Goldman JM, Goren EN, Cohen MH, Webber BL, Brennan MF, Robbins J. Anaplastic thyroid carcinoma: long-term survival after radical surgery. J Surg Oncol. 1980; 14:389-394.
7. Kasai N, Sakamoto A, Uchida M. A combined modality for anaplastic large-cell carcinoma of the thyroid. Auris Nasus Larynx. 1985;12(Suppl 2):S72-S74.
8. Kim JH, Leeper RD. Treatment of locally advanced thyroid carcinoma with combination doxorubicin and radiation therapy. Cancer. 1987;60:2372-2375.
9. Pierie JP, Muzikansky A, Gaz RD, Faquin WC, Ott MJ. The effect of surgery and radiotherapy on outcome of anaplastic thyroid carcinoma. Ann Surg Oncol. 2002;9:57-64.
10. Schlumberger M, Parmentier C, Delisle MJ, Couette JE, Droz JP, Sarrazin D. Combination therapy for anaplastic giant cell thyroid carcinoma. Cancer. 1991;67:564-566.
11. Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A. Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid. World J Surg. 2001;25:617-622.
12. Tallroth E, Wallin G, Lundell G, Lowhagen T, Einhorn J. Multimodality treatment in anaplastic giant cell thyroid carcinoma. Cancer. 1987;60:1428-1431.
13. Tennvall J, Lundell G, Hallquist A, Wahlberg P, Wallin G, Tibblin S. Combined doxorubicin, hyperfractionated radiotherapy, and surgery in anaplastic thyroid carcinoma. Report on two protocols. The Swedish Anaplastic Thyroid Cancer Group. Cancer. 1994;74:1348-1354.
14. Tennvall J, Lundell G, Wahlberg P, et al. Anaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery. Br J Cancer. 2002;86: 1848-1853.
15. Werner B, Abele J, Alveryd A, et al. Multimodal therapy in anaplastic giant cell thyroid carcinoma. World J Surg. 1984; 8:64-70.
16. Haigh PI, Ituarte PH, Wu HS, et al. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival. Cancer. 2001;91:2335-2342.
17. Sherman SI. Thyroid carcinoma. Lancet. 2003;361:501-511.
18. Pasieka JL. Anaplastic thyroid cancer. Curr Opin Oncol. 2003;15:78-83.
19. Greene FL, Page DL, Fleming ID, et al., editors. Thyroid. AJCC cancer staging manual. 6th edition. New York: Springer-Verlag, 2002:77.
20. Surveillance, Epidemiology, and End Results Program. Serial online. Available at URL: http://www.seer.cancer.gov/publicdata/ [accessed November 11, 2003].
21. Surveillance, Epidemiology, and End Results Program. Monograph online. Available at URL: http://seer.cancer-.gov/tools/codingmanuals/ [accessed November 11, 2003].
22. Besic N, Auersperg M, Us-Krasovec M, Golouh R, Frkovic-Grazio S, Vodnik A. Effect of primary treatment on survival in anaplastic thyroid carcinoma. Eur J Surg Oncol. 2001;27: 260-264.
23. Jereb B, Stjernsward J, Lowhagen T. Anaplastic giant-cell carcinoma of the thyroid. A study of treatment and prognosis. Cancer. 1975;35:1293-1295.
24. Junor EJ, Paul J, Reed NS. Anaplastic thyroid carcinoma: 91 patients treated by surgery and radiotherapy. Eur J Surg Oncol. 1992;18:83-88.
25. Kobayashi T, Asakawa H, Umeshita K, et al. Treatment of 37 patients with anaplastic carcinoma of the thyroid. Head Neck. 1996;18:36-41.
26. Nilsson O, Lindeberg J, Zedenius J, et al. Anaplastic giant cell carcinoma of the thyroid gland: treatment and survival over a 25-year period. World J Surg. 1998;22:725-730.
27. Carcangiu ML, Steeper T, Zampi G, Rosai J. Anaplastic thyroid carcinoma. A study of 70 cases. Am J Clin Pathol. 1985;83:135-158.
28. McIver B, Hay ID, Giuffrida DF, et al. Anaplastic thyroid carcinoma: a 50-year experience at a single institution. Surgery. 2001;130:1028-1034.
29. Pacheco-Ojeda LA, Martinez AL, Alvarez M. Anaplastic thyroid carcinoma in Ecuador: analysis of prognostic factors. Int Surg. 2001;86:117-121.
30. Tan RK, Finley RK 3rd, Driscoll D, Bakamjian V, Hicks WL Jr., Shedd DP. Anaplastic carcinoma of the thyroid: a 24-year experience. Head Neck. 1995;17:41-47; discussion, 47-48.
31. Demeter JG, De Jong SA, Lawrence AM, Paloyan E. Anaplastic thyroid carcinoma: risk factors and outcome. Surgery. 1991;110:956-961; discussion, 961-963.
32. Venkatesh YS, Ordonez NG, Schultz PN, Hickey RC, Goepfert H, Samaan NA. Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases. Cancer. 1990;66:321-330.
33. Lo CY, Lam KY, Wan KY. Anaplastic carcinoma of the thyroid. Am J Surg. 1999;177:337-339.
34. Haigh PI. Anaplastic thyroid carcinoma. Curr Treat Options Oncol. 2000;1:353-357.
35. Ain KB, Egorin MJ, DeSimone PA. Treatment of anaplastic thyroid carcinoma with paclitaxel: Phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group. Thyroid. 2000;10:587-594.
36. [No authors listed.] Intensive chemotherapy for anaplastic thyroid carcinoma: combination of cisplatin, doxorubicin, etoposide and peplomycin with granulocyte colony-stimulating factor support. Chemotherapy Committee, The Japanese Society of Thyroid Surgery. Jpn J Clin Oncol. 1995;25: 203-207.
37. De Besi P, Busnardo B, Toso S, et al. Combined chemotherapy with bleomycin, Adriamycin, and platinum in advanced thyroid cancer. J Endocrinol Invest. 1991;14:475-480.
38. Williams SD, Birch R, Einhorn LH. Phase II evaluation of doxorubicin plus cisplatin in advanced thyroid cancer: a Southeastern Cancer Study Group trial. Cancer Treat Rep. 1986;70:405-407.